78 Is Genomic Laboratory Hub NSCLC Testing Compatible With The National Optimal Lung Cancer Pathway? A 6 year time series analysis

Lung Cancer 2026

View at publisher

Authors: David Allan Moore, Amali Jayathilaka, Fleur Monk, Sreeja Biswas Roy, Ross Leaver, Neal Navani, Tanya Ahmad

DOI: 10.1016/j.lungcan.2026.109027

Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Diagnosis and Treatment Cancer Genomics and Diagnostics